Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -.--% | -.--% |
May. 07 | Deutsche Bank Initiates Bunzl at Hold | MT |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 11.93B 15.15B | Sales 2025 * | 12.36B 15.7B | Capitalization | 10.22B 12.98B |
---|---|---|---|---|---|
Net income 2024 * | 518M 658M | Net income 2025 * | 553M 702M | EV / Sales 2024 * | 0.99 x |
Net Debt 2024 * | 1.6B 2.03B | Net Debt 2025 * | 1.22B 1.55B | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
18.7
x | Employees | - |
Yield 2024 * |
2.35% | Yield 2025 * |
2.48% | Free-Float | 99.16% |
Latest transcript on Bunzl
Managers | Title | Age | Since |
---|---|---|---|
Frank van Zanten
CEO | Chief Executive Officer | 57 | - |
Richard Howes
DFI | Director of Finance/CFO | 55 | 19-08-31 |
Mark Jordan
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Ventress
CHM | Chairman | 62 | 19-05-31 |
Pamela Kirby
BRD | Director/Board Member | 70 | 22-07-31 |
Vinodka Murria
BRD | Director/Board Member | 62 | 20-05-31 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.63% | 88.45B | |
+50.40% | 76.76B | |
+25.78% | 67.15B | |
+7.42% | 41.88B | |
+33.58% | 32.3B | |
+34.26% | 32.19B | |
+15.32% | 21.69B | |
+17.22% | 18.1B | |
+33.66% | 5.95B |
- Stock Market
- Equities
- BNZL Stock
- BNZL Stock